Bayer announced that their trial of a 500 mcg dose of betaseron failed to meet its primary end point. I removed it from the phase 3 list.
Bayer announced that their trial of a 500 mcg dose of betaseron failed to meet its primary end point. I removed it from the phase 3 list.
